Patents by Inventor Guofeng Cheng

Guofeng Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING HEPATITIS B VIRUS
    Publication number: 20180042905
    Abstract: The present invention relates to novel methods of treating Hepatitis B Virus by administering a KDM5 inhibitor.
    Type: Application
    Filed: August 29, 2017
    Publication date: February 15, 2018
    Inventors: Esmeralda Aguayo, Todd Appleby, Gabriel Birkus, Guofeng Cheng, David Dornan, Tetsuya Kobayashi, Christopher Charles Mello, Uli Schmitz, Madeleine Willkom, Mei Yu
  • METHODS OF TREATING HEPATITIS B VIRUS
    Publication number: 20160303095
    Abstract: The present invention relates to novel methods of treating Hepatitis B Virus by administering a KDM5 inhibitor.
    Type: Application
    Filed: April 13, 2016
    Publication date: October 20, 2016
    Inventors: Esmeralda Aguayo, Todd Appleby, Gabriel Birkus, Guofeng Cheng, David Dornan, Tetsuya Kobayashi, Christopher Charles Mello, Uli Schmitz, Madeleine Willkom, Mei Yu
  • HCV genotype 6 replicons
    Patent number: 9353423
    Abstract: Replicons of genotype 6 hepatitis C virus (HCV) are provided. These replicons contain adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 6 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: May 31, 2016
    Assignee: Gilead Sciences, Inc.
    Inventors: Guofeng Cheng, William E. Delaney, IV, Betty Peng, Mei Yu
  • HCV genotype 3 replicons
    Patent number: 8889848
    Abstract: Replicons of genotype 3 of hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 3 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: November 18, 2014
    Assignee: Gilead Sciences, Inc.
    Inventors: William E. Delaney, IV, Guofeng Cheng, Hongmei Mo, Simin Xu, Mei Yu, Amoreena Corsa
  • HCV genotype 4 replicons
    Patent number: 8889849
    Abstract: Replicons of genotype 4 hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 4 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: November 18, 2014
    Assignee: Gilead Sciences, Inc.
    Inventors: William E. Delaney, IV, Guofeng Cheng, Hongmei Mo, Simin Xu, Betty Peng
  • HCV GENOTYPE 6 REPLICONS
    Publication number: 20140134604
    Abstract: Replicons of genotype 6 hepatitis C virus (HCV) are provided. These replicons contain adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 6 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Application
    Filed: November 6, 2013
    Publication date: May 15, 2014
    Inventors: Guofeng Cheng, William E. Delaney, IV, Betty Peng, Mei Yu
  • HCV GENOTYPE 4 REPLICONS
    Publication number: 20130052634
    Abstract: Replicons of genotype 4 hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 4 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Application
    Filed: July 5, 2012
    Publication date: February 28, 2013
    Inventors: William E. Delaney, IV, Guofeng Cheng, Hongmei Mo, Simin Xu, Betty Peng
  • HCV GENOTYPE 3 REPLICONS
    Publication number: 20130052633
    Abstract: Replicons of genotype 3 of hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 3 replicons and methods of using these replicons to screen antiviral agents are also provided.
    Type: Application
    Filed: July 5, 2012
    Publication date: February 28, 2013
    Applicant: Gilead Sciences, Inc.
    Inventors: William E. Delaney, IV, Guofeng Cheng, Hongmei Mo, Simin Xu, Mei Yu, Amoreena Corsa